Welcome to CLS

The leading supplier of the products for Core Life Source Inc., Global Life Laboratory Corp. (GLLC), is a leading alternative medicine/nutraceutical producer in the U.S. The leading scientist, the founder and a Board Member of GLLC, Darrick S. Kim, Ph.D., is a holder of over eleven approved patents and several pending patents on the discovery of anticancer agents and anti-beta-amyloid agents from the natural resources. His accomplishments have been published in numerous scientific journals and featured in newspaper articles. Dr. Darrick S. Kim holds several patents on the discovery of biologically active constituents from the natural resources that vitalize neuronal cells and protect these cells from beta-amyloid insult. He is the discoverer and the patent holder of curcuminoids found in turmeric, in addition to dozens more natural compounds from ginger, ginkgo, sage, rosemary and others…, for potential prevention and treatment against beta-amyloid induced diseases such as Alzheimer’s disease.

Do you remember the dreams and plans you had when you were graduating high school and college (we want to coin the term “dream of our youth”)? How many of us have achieved the dreams, we wonder. Now, we are older and have much experience in life, how we long to achieve the dream if we can get a second chance in life to achieve the dream of our youth?

The goal of Core Life Source, Inc. is to provide our clients a potential pathway to achieving their dream of our youth through natural means. It is well recognized that when well-being of brain function is achieved, the well-being of life will follow; through which, youthful vigor of life is achieved ? a possible pathway to anti-aging process. Each one of us has the choice to achieving the well-being of life and the dream of our youth. This is our lot. No one else has claim on this. We hope you would join us in our quest. Do it for Your Life. If you have any question, do not hesitate to contact us.

Food and Drug Administration’s Ruling on CLSI Products

All CLSI products contain natural substances abundant in medicinal plants that have been scientifically proven to protect cells that are important for certain body functions from harmful agents that cause the onset of unwanted aging-associated diseases.

All CLSI products are manufactured using Global Life Laboratory Corporation’s unique proprietary technologies under a strict Food and Drug Administration (FDA)’s current Good Manufacturing Practice (cGMP) guideline, and the natural substances therein are patent protected. The medicinal plants and the biologically active natural substances present therein that constitute CLSI products have been intensely investigated by scientists over several decades to prove their safety and bioefficacy. All CLSI products are manufactured in the USA according to the guidelines set forth by the Food and Drug Administration (FDA). Due to the nature and properties of complementary and alternative medicine and the definitions thereof established by FDA, all CLSI products are manufactured according to the strict guideline established by FDA’s “Dietary Supplement Health and Education Act (DSHEA) (Pub. L. 103-417) signed into law on October 25, 1994.”

In October 1994, the Dietary Supplement Health and Education Act (DSHEA) was signed into law by President Clinton. Before this time, dietary supplements were subject to the same regulatory requirements as were other foods. This new law, which amended the Federal Food, Drug, and Cosmetic Act, created a new regulatory framework for the safety and labeling of dietary supplements. (Note**: For additional information, please consult FDA’s ruling on complementary and alternative medicine and dietary supplements.)



Core LifeSource, Inc. (CLSI) is a nutra-pharmaceutical company that focuses on manufacturing, distributing, and marketing products designed to improve the health and the lifestyle of aging man and woman alike through means of complementary and alternative medicine.

CLSI was founded on an understanding that everyone will need to deal with and overcome debilitating aging-associated diseases. CLSI is striving to be a healthcare leader for aging population by providing methods and means to overcome debilitating aging-associated diseases.

The current trend in the development of medical technologies and understanding of diseases and treatment has been causing the rise of expected lifespan of human to an unexpectedly profound level, resulting in a large increase of aging population. However, aging-associated diseases continue to plague us, and the battle against these diseases is far from being under control. Some examples of such disease are Alzheimer’s disease, diabetes, and osteoporosis. Thus these aging-associated diseases become major economic and health concerns in the new millennium.

Biographical Sketch

B.S. degrees in both biology and chemistry from University of California, Irvine
M.S. degree in organic chemistry from University of California, Irvine
Ph.D. degree in organic syntheses of natural products & Drug Discovery from University of California, Irvine
Postdoctoral tenure at College of Pharmacy, Purdue University, West Lafayette, Indiana
Professor of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, University of Illinois, Chicago

Founder/CEO of CurXceL corp. (R&D Biopharmaceutical Company).
Founder/Member of the Board of Directors of Global Life Laboratory Corp. (Alternative Health product Company – AmyNex-1, AmyNex-II, AmyNex-W, AmyNex-S, Alpha-Xyl, NeuroZyne-A, NeuroZyne-X and more).
Founder/Executive Science & Technology Officer of JorDar Corp. (High-Tech Human and Environmental Health Products).
Founder/CEO of Core LifeSource Inc. (Alternative Medicinal Health Products Marketing Company).

Author of over 30 publications in scientific journals and several book chapters.

Fourteen U.S. and world patents.
Twelve pending patents.

Major Discoveries:
Drug candidates for treatment and prevention of Alzheimer Disease.
Drug candidates for treatment against cancer, in particular, prostate cancer.
Drug candidates and formulations for inflammatory diseases of the joint.
An approach to treat and prevent glaucoma and macular degeneration.

Non-scientific special interests:
He enjoys song writing (over 300 original songs in both pop rock and gospel.) He plays guitar and was a leader of a rock band during his college year. He won the first place at a rock music contest (1988), and creativity award at a gospel song competition (1989). He continues to write songs. He currently is working on a project to publish music CD of his original songs he recently wrote.








jaltmed kim

calebin-a article


6-kim curc neurosci let